GPCR crystal structures: Medicinal chemistry in the pocket.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2015-07-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2014.12.034PMID 25638496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biased Agonism at G Protein‐Coupled Receptors: The Promise and the Challenges—A Medicinal Chemistry Perspective

  2014cited by this paper
• Molecular control of δ-opioid receptor signalling

  2014cited by this paper
• Muscarinic acetylcholine receptors: novel opportunities for drug development

  2014cited by this paper
• Discovery and Characterization of a G Protein–Biased Agonist That Inhibits β-Arrestin Recruitment to the D2 Dopamine Receptor

  2014cited by this paper
• An update on the biology of sphingosine 1-phosphate receptors

  2014cited by this paper
• High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875

  2014cited by this paper
• Covalent agonists for studying G protein-coupled receptor activation

  2014cited by this paper
• Dual Histamine H3R/Serotonin 5-HT4R Ligands with Antiamnesic Properties: Pharmacophore-Based Virtual Screening and Polypharmacology

  2014cited by this paper
• Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator

  2014cited by this paper
• Adenosine A2A Receptor Antagonists in Parkinson’s Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued

  2014cited by this paper
• Relevance of rhodopsin studies for GPCR activation.

  2014cited by this paper
• Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli

  2014cited by this paper
• Structure of the human P2Y12 receptor in complex with an antithrombotic drug

  2014cited by this paper
• Targeting of Smoothened for therapeutic gain.

  2014cited by this paper
• Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography

  2014cited by this paper
• Muscarinic acetylcholine receptor X-ray structures: potential implications for drug development.

  2014cited by this paper
• Allosteric sodium in class A GPCR signaling.

  2014cited by this paper
• A new mechanism of allostery in a G protein-coupled receptor dimer

  2014cited by this paper
• The 2.1 Å Resolution Structure of Cyanopindolol-Bound β1-Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free Receptor

  2014cited by this paper
• The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin.

  2014cited by this paper
• Position of transmembrane helix 6 determines receptor G protein coupling specificity.

  2014cited by this paper
• Structure‐Based and Fragment‐Based GPCR Drug Discovery

  2014cited by this paper
• Agonist-bound structure of the human P2Y12 receptor

  2014cited by this paper
• Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxar.

  2014cited by this paper
• Functionally selective dopamine D₂, D₃ receptor partial agonists.

  2014cited by this paper
• AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterization.

  2014cited by this paper
• Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain

  2014cited by this paper
• Identification of Determinants Required for Agonistic and Inverse Agonistic Ligand Properties at the ADP Receptor P2Y12

  2013cited by this paper
• Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex

  2013cited by this paper
• Structure of the human smoothened receptor bound to an antitumour agent

  2013cited by this paper
• The structural basis of G-protein-coupled receptor signaling (Nobel Lecture).

  2013cited by this paper
• The dynamic process of β(2)-adrenergic receptor activation.

  2013cited by this paper
• Activation and allosteric modulation of a muscarinic acetylcholine receptor

  2013cited by this paper
• Structure of the human glucagon class B G-protein-coupled receptor

  2013cited by this paper
• Biophysical Fragment Screening of the β1-Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug Design

  2013cited by this paper
• Structure of class B GPCR corticotropin-releasing factor receptor 1

  2013cited by this paper
• Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody

  2013cited by this paper
• Mapping histamine H4 receptor–ligand binding modes

  2013cited by this paper
• Unlocking the secrets of the gatekeeper: methods for stabilizing and crystallizing GPCRs.

  2013cited by this paper
• Active-State Models of Ternary GPCR Complexes: Determinants of Selective Receptor-G-Protein Coupling

  2013cited by this paper
• Structural Basis for Molecular Recognition at Serotonin Receptors

  2013cited by this paper
• Crystal Structure of Oligomeric β1-Adrenergic G Protein- Coupled Receptors in Ligand-Free Basal State

  2013cited by this paper
• Bridging the gap: bitopic ligands of G-protein-coupled receptors.

  2013cited by this paper
• In vitro and mouse in vivo characterization of the potent free fatty acid 1 receptor agonist TUG-469

  2013cited by this paper
• A structure-activity analysis of biased agonism at the dopamine D2 receptor.

  2013cited by this paper
• Functionally selective dopamine D2/D3 receptor agonists comprising an enyne moiety.

  2013cited by this paper
• Docking and MD study of histamine H4R based on the crystal structure of H1R.

  2013cited by this paper
• Serial Femtosecond Crystallography of G Protein–Coupled Receptors

  2013cited by this paper
• Adenosine receptors as drug targets — what are the challenges?

  2013cited by this paper
• Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.

  2013cited by this paper
• A brief history of G-protein coupled receptors (Nobel Lecture).

  2013cited by this paper
• Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor.

  2013cited by this paper
• Emerging paradigms in GPCR allostery: implications for drug discovery

  2013cited by this paper
• Structure-Based Ligand Discovery Targeting Orthosteric and Allosteric Pockets of Dopamine Receptors

  2013cited by this paper
• Structural Features for Functional Selectivity at Serotonin Receptors

  2013cited by this paper
• Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists.

  2013cited by this paper
• Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor

  2012cited by this paper
• Agonist-bound structures of G protein-coupled receptors.

  2012cited by this paper
• Structure of the human kappa opioid receptor in complex with JDTic

  2012cited by this paper
• Crystal structure of the μ-opioid receptor bound to a morphinan antagonist

  2012cited by this paper
• In Silico screening for agonists and blockers of the β2 adrenergic receptor: Implications of inactive and activated state structures

  2012cited by this paper
• Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design

  2012cited by this paper
• Structure of the δ-opioid receptor bound to naltrindole

  2012cited by this paper
• N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor

  2012cited by this paper
• Crystal Structure of a Lipid G Protein–Coupled Receptor

  2012cited by this paper
• Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol

  2012cited by this paper
• Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening.

  2012cited by this paper
• High-resolution crystal structure of human Protease-Activated Receptor 1 bound to the antagonist vorapaxar

  2012cited by this paper
• Structure-based ligand discovery for the protein–protein interface of chemokine receptor CXCR4

  2012cited by this paper
• New Insights for Drug Design from the X-Ray Crystallographic Structures of G-Protein-Coupled Receptors

  2012cited by this paper
• Structure of the agonist-bound neurotensin receptor

  2012cited by this paper
• TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.

  2012cited by this paper
• Molecular determinants of ligand binding at the human histamine H1 receptor: Site-directed mutagenesis results analyzed with ligand docking and molecular dynamics studies at H1 homology and crystal structure models.

  2012cited by this paper
• Biased Signaling Pathways in β2-Adrenergic Receptor Characterized by 19F-NMR

  2012cited by this paper
• Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic

  2012cited by this paper
• Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors.

  2012cited by this paper
• Virtual Fragment Screening: Discovery of Histamine H3 Receptor Ligands Using Ligand-Based and Protein-Based Molecular Fingerprints

  2012cited by this paper
• Basic opioid pharmacology: an update

  2012cited by this paper
• Two distinct conformations of helix 6 observed in antagonist-bound structures of a β1-adrenergic receptor

  2011cited by this paper
• Discovery of phosphoric acid mono-{2-[(E/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl} ester (Lu AA47070): a phosphonooxymethylene prodrug of a potent and selective hA(2A) receptor antagonist.

  2011cited by this paper
• Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.

  2011cited by this paper
• Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation

  2011cited by this paper
• Structure of the human histamine H1 receptor complex with doxepin

  2011cited by this paper
• A Novel Nonribose Agonist, LUF5834, Engages Residues That Are Distinct from Those of Adenosine-Like Ligands to Activate the Adenosine A2a Receptor

  2011cited by this paper
• Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist

  2011cited by this paper
• Structure of an Agonist-Bound Human A2A Adenosine Receptor

  2011cited by this paper
• Recent Advances in the Development of Dopamine D3 Receptor Antagonists: a Medicinal Chemistry Perspective

  2011cited by this paper
• A novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor.

  2011cited by this paper
• Ligand Discovery from a Dopamine D3 Receptor Homology Model and Crystal Structure

  2011cited by this paper
• Design Strategies for Bivalent Ligands Targeting GPCRs

  2011cited by this paper
• The Physiology, Signaling, and Pharmacology of Dopamine Receptors

  2011cited by this paper
• AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome.

  2011cited by this paper
• Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates.

  2011cited by this paper
• mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents.

  2011cited by this paper
• Recent developments in adenosine receptor ligands and their potential as novel drugs.

  2011cited by this paper
• N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.

  2011cited by this paper
• Activation mechanism of the β2-adrenergic receptor

  2011cited by this paper
• Crystal Structure of the β2Adrenergic Receptor-Gs protein complex

  2011cited by this paper
• Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.

  2011cited by this paper
• Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment.

  2011cited by this paper

• Selective, Non-nucleotidic Radiotracer for P2Y12 Receptors: Design, Synthesis, Characterization, and Imaging of Brain Slices.

  2025cites this paper
• Ligand-induced conformational changes in the β1-adrenergic receptor revealed by hydrogen-deuterium exchange mass spectrometry

  2024cites this paper
• G Protein-Coupled Receptor–Ligand Pose and Functional Class Prediction

  2024cites this paper
• A head-to-head comparison of MM/PBSA and MM/GBSA in predicting binding affinities for the CB1 cannabinoid ligands

  2024cites this paper
• Cannabidiol at Nanomolar Concentrations Negatively Affects Signaling through the Adenosine A2A Receptor

  2023cites this paper
• Simple purification of small-molecule-labelled peptides via palladium enolate formation from β-ketoamide tags

  2023cites this paper
• The Chemerin Receptor CMKLR1 Requires Full‐Length Chemerin for High Affinity in Contrast to GPR1 as Demonstrated by a New Nanoluciferase‐Based Binding Assay

  2022cites this paper
• Photoswitchable allosteric modulators for metabotropic glutamate receptors.

  2022cites this paper
• Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery

  2021cites this paper
• Structure and dynamics of the somatostatin receptor 3‐ligand binding in the presence of lipids examined using computational structural biology methods

  2021influential citation
• Structural Insights into Ligand—Receptor Interactions Involved in Biased Agonism of G-Protein Coupled Receptors

  2021influential citation
• Molecular interaction of HIC, an agonist of P2Y1 receptor, and its role in prostate cancer apoptosis.

  2021cites this paper
• Characterization of ZmCOLD1, novel GPCR-Type G Protein genes involved in cold stress from Zea mays L. and the evolution analysis with those from other species

  2021cites this paper
• Characterizing Interhelical Interactions of G-Protein Coupled Receptors with the Fragment Molecular Orbital Method

  2020cites this paper
• Analyzing GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.

  2020cites this paper
• Quantum Mechanics in Drug Discovery

  2020cites this paper
• Structural diversity in ligand recognition by GPCRs

  2020cites this paper
• Virtual Screening and In Silico Simulation Analysis for Rapid and Efficient Identification of Novel Natural GPR40 Agonist

  2020cites this paper
• Drug Targets

  2020cites this paper
• Gonadotropin-releasing hormone analogs: mechanisms of action and clinical applications in female reproduction.

  2020cites this paper
• EXPLORING THE CONFORMATIONAL LANDSCAPE OF BIOACTIVE SMALL MOLECULES.

  2020cites this paper
• The effect of multiple simulation parameters on MM/PBSA performance for binding affinity prediction of CB1 cannabinoid receptor agonists and antagonists

  2020cites this paper
• Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt1]DALDA, and KGOP01, Binding to the Mu Opioid Receptor

  2020cites this paper
• The computational modeling of allosteric modulation of metabotropic glutamate receptors.

  2020cites this paper
• Guiding Medicinal Chemistry with Fragment Molecular Orbital (FMO) Method.

  2020cites this paper
• Allosteric modulation of G protein‐coupled receptors by amiloride and its derivatives. Perspectives for drug discovery?

  2019cites this paper
• A Receptor Model With Binding Affinity, Activation Efficacy, and Signal Amplification Parameters for Complex Fractional Response Versus Occupancy Data

  2019influential citation
• Purinergic signalling in human adipose-derived mesenchymal stromal cells and in vitro differentiated adipocytes

  2019cites this paper
• Theoretical Coupling and Stability of Boronic Acid Adducts with Catecholamines

  2019cites this paper
• The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?

  2019cites this paper
• Polymorphs, co-crystal structure and pharmacodynamics study of MBRI-001, a deuterium-substituted plinabulin derivative as a tubulin polymerization inhibitor.

  2019cites this paper
• Ensemble-Based Steered Molecular Dynamics Predicts Relative Residence Time of A2A Receptor Binders.

  2019cites this paper
• The Dopaminergic System

  2019cites this paper
• Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs

  2019cites this paper
• Hydrogen bond dynamics and conformational flexibility in antipsychotics.

  2019cites this paper
• Identification of novel G-protein-coupled receptor 40 (GPR40) agonists by hybrid in silico-screening techniques and molecular dynamics simulations thereof

  2018cites this paper
• Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment.

  2018cites this paper
• Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.

  2018cites this paper
• Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design

  2018cites this paper
• Structural Investigation of the Dopamine-2 Receptor Agonist Bromocriptine Binding to Dimeric D2HighR and D2LowR States

  2018cites this paper
• Structural Mapping of Adenosine Receptor Mutations: Ligand Binding and Signaling Mechanisms.

  2018cites this paper
• Using molecular dynamics for the refinement of atomistic models of GPCRs by homology modeling

  2018cites this paper
• Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.

  2018cites this paper
• Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.

  2018cites this paper
• Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery.

  2018cites this paper
• Modeling and Deorphanization of Orphan GPCRs.

  2018cites this paper
• Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells

  2018cites this paper
• Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges

  2018cites this paper
• Gonadotropin-releasing hormone analog therapeutics.

  2018cites this paper
• Evidence of Alternative Splicing as a Regulatory Mechanism for Kissr2 in Pejerrey Fish

  2018cites this paper
• GPRC5A: An Emerging Biomarker in Human Cancer

  2018cites this paper
• An Opioid-benzodiazepine Interaction: Benzodiazepines as Opioids?

  2018cites this paper
• Etude pharmacochimique du système 26RFa/QRFPR : synthèse d'analogues peptidiques, activité biologique in vitro et in vivo et interactions moléculaires

  2018cites this paper
• Allosteric interactions between catecholamine receptors and other G protein-coupled receptors: Pharmacological and functional characterization

  2018cites this paper
• Discovery of OX1 and OX2 orexin receptor ligands

  2018cites this paper
• Heterómeros de receptores CB1, CB2 y GPR55 y su implicación en enfermedades neurodegenerativas y alcoholismo

  2018cites this paper
• Heterómeros de receptores de dopamina d1 y de histamina h3 como potenciales dianas terapéuticas en trastornos adictivos y enfermedades neurodegenerativas

  2018cites this paper
• Rapid and accurate assessment of GPCR–ligand interactions Using the fragment molecular orbital‐based density‐functional tight‐binding method

  2017cites this paper
• Photoaffinity Labeling in Drug Discovery Research

  2017cites this paper
• Discovery of Novel Indazole Derivatives as Orally Available β3-Adrenergic Receptor Agonists Lacking Off-Target-Based Cardiovascular Side Effects.

  2017cites this paper
• Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D3 Receptor (D3R).

  2017cites this paper
• Photoaffinity Labeling of the Human A2A Adenosine Receptor and Cross-link Position Analysis by Mass Spectrometry.

  2017cites this paper
• Structure and dynamics of GPCR signaling complexes

  2017cites this paper
• Potent haloperidol derivatives covalently binding to the dopamine D2 receptor.

  2017cites this paper
• Biological Insights of the Dopaminergic Stabilizer ACR16 at the Binding Pocket of Dopamine D2 Receptor.

  2017cites this paper
• Flavonoid allosteric modulation of mutated visual rhodopsin associated with retinitis pigmentosa

  2017cites this paper
• Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening.

  2017cites this paper
• Complex Pharmacology of Free Fatty Acid Receptors.

  2017cites this paper
• Human Cannabinoid Receptor 2 Ligand-Interaction Motif: Transmembrane Helix 2 Cysteine, C2.59(89), as Determinant of Classical Cannabinoid Agonist Activity and Binding Pose.

  2017cites this paper
• G protein-coupled receptors: the evolution of structural insight.

  2017cites this paper
• An Ensemble-Based Protocol for the Computational Prediction of Helix–Helix Interactions in G Protein-Coupled Receptors using Coarse-Grained Molecular Dynamics

  2017cites this paper
• Biophysical and functional characterization of the human olfactory receptor OR1A1 expressed in a mammalian inducible cell line.

  2017cites this paper
• Development of a GRK 2-inhibitory peptide

  2017cites this paper
• Modélisation moléculaire de la perception de la saveur sucrée : approches structurales et dynamiques

  2017cites this paper
• Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.

  2017cites this paper
• Pharmacological Characterization of Human Histamine Receptors and Histamine Receptor Mutants in the Sf9 Cell Expression System

  2017cites this paper
• A structurally guided dissection-then-evolution strategy for ligand optimization of smoothened receptor

  2017cites this paper
• Photoaffinity Labeling for Structural Probing Within Protein

  2017cites this paper
• Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT1A receptor in the treatment of major depressive disorder.

  2017cites this paper
• Analysis of natural product regulation of opioid receptors in the treatment of human disease.

  2017cites this paper
• Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking.

  2017cites this paper
• NanoBRET Approaches to Study Ligand Binding to GPCRs and RTKs.

  2017cites this paper
• Measurement of intracellular Ca2+ mobilization to study GPCR signal transduction.

  2017cites this paper
• Analysis of Glutamate Agonist LY 404 , 039 at Dopamine Receptor D 2 Dimeric Models Using Multiscale Molecular Modeling Approaches

  2017cites this paper
• The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR-Ligand Interactions

  2016cites this paper
• Multiscale design of coarse-grained elastic network-based potentials for the μ opioid receptor

  2016cites this paper
• Serial Femtosecond Crystallography of Membrane Proteins.

  2016cites this paper
• Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.

  2016cites this paper
• Small Molecule CXCR3 Antagonists.

  2016cites this paper
• Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists.

  2016cites this paper
• University of Dundee Membrane Potentials Regulating GPCRs

  2016cites this paper
• Orexin Receptor Antagonists: Historical Perspectives and Future Opportunities.

  2016cites this paper
• Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.

  2016cites this paper
• Fragment Molecular Orbital Method Applied to Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors.

  2016cites this paper
• G-Protein/β-Arrestin-Linked Fluctuating Network of G-Protein-Coupled Receptors for Predicting Drug Efficacy and Bias Using Short-Term Molecular Dynamics Simulation

  2016cites this paper
• Identification of Two Distinct Sites for Antagonist and Biased Agonist Binding to the Human Chemokine Receptor CXCR3.

  2016cites this paper
• The Quantum Nature of Drug-Receptor Interactions: Deuteration Changes Binding Affinities for Histamine Receptor Ligands

  2016cites this paper
• Using the fragment molecular orbital method to investigate agonist–orexin-2 receptor interactions

  2016cites this paper
• Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target

  2016cites this paper
• Development of Covalent Ligand-Receptor Pairs to Study the Binding Properties of Nonpeptidic Neurotensin Receptor 1 Antagonists.

  2016cites this paper